Lv71
3305 积分 2021-04-30 加入
Nirogacestat: First Approval
51分钟前
已完结
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
52分钟前
已完结
Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease
1小时前
已关闭
Current Management of Desmoid Tumors: A Review
1小时前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
1个月前
已完结
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer
2个月前
已完结
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
2个月前
已完结
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
5个月前
已完结
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
5个月前
已完结
BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis
5个月前
已完结
皖公网安备34019202002308
